COST-EFFECTIVENESS OF RIOCIGUAT FOR TREATMENT OF PATIENTS WITH INOPERABLE OR POST-OPERATIVE RECURRENT/PERSISTENT CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH) IN TURKEY
dc.contributor.author | Erdal, E. | |
dc.contributor.author | Ozdemir, O. | |
dc.contributor.author | Yildizeli, B. | |
dc.contributor.author | Kaymaz, C. | |
dc.contributor.author | Okumus, G. | |
dc.contributor.author | Mogulkoc, N. | |
dc.contributor.author | Nalbantgil, S. | |
dc.contributor.author | Deger, C. | |
dc.contributor.author | Sumer, F. | |
dc.contributor.author | Parali, E. | |
dc.contributor.author | Tunalioglu, A. | |
dc.contributor.author | Sar, C. | |
dc.contributor.author | Asan, S. | |
dc.contributor.author | Ozel, O. | |
dc.date.accessioned | 2019-10-27T22:27:03Z | |
dc.date.available | 2019-10-27T22:27:03Z | |
dc.date.issued | 2015 | |
dc.department | Ege Üniversitesi | en_US |
dc.identifier.doi | 10.1016/j.jval.2015.03.822 | |
dc.identifier.endpage | A141 | en_US |
dc.identifier.issn | 1098-3015 | |
dc.identifier.issn | 1524-4733 | |
dc.identifier.issue | 3 | en_US |
dc.identifier.startpage | A141 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.jval.2015.03.822 | |
dc.identifier.uri | https://hdl.handle.net/11454/50551 | |
dc.identifier.volume | 18 | en_US |
dc.identifier.wos | WOS:000354498502162 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Science Inc | en_US |
dc.relation.ispartof | Value in Health | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.title | COST-EFFECTIVENESS OF RIOCIGUAT FOR TREATMENT OF PATIENTS WITH INOPERABLE OR POST-OPERATIVE RECURRENT/PERSISTENT CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH) IN TURKEY | en_US |
dc.type | Conference Object | en_US |